Skip to main content
Erschienen in: World Journal of Urology 9/2019

17.12.2018 | Original Article

Comparison of biopsy devices in upper tract urothelial carcinoma

verfasst von: Alberto Breda, Angelo Territo, Francesco Sanguedolce, Giuseppe Basile, Jose D. Subiela, Helena Vila Reyes, Olga Mayordomo Ferrer, Jose M. Gaya, Joan Palou

Erschienen in: World Journal of Urology | Ausgabe 9/2019

Einloggen, um Zugang zu erhalten

Abstract

Introduction

A correct characterization of upper tract urothelial carcinoma (UTUC) lesions is fundamental to appropriately select patients suitable for endoscopic management. We analyzed the diagnostic yield of three different biopsy tools for the histology evaluation of the UTUC. Furthermore, the concordance between biopsy grading and final UTUC pathology results at specimen (i.e., after ureterectomy or radical nephroureterectomy—RNU) was evaluated.

Materials and methods

Three different devices were evaluated: 3F biopsy forceps, 6F BIGopsy® Backloading biopsy forceps and the 2.2F Nitinol Basket. Data were collected between January 2015 and October 2017 and retrospectively analyzed. Univariate and multivariate logistic regression analyses were performed to identify the variables related to diagnosis.

Results

A total of 302 biopsies were taken: lesions could be characterized in 236 (78.2%) specimens by the pathologist. Positive biopsies for UTUC were found in 140 specimens. In 66 biopsies (21.8%), the quality of the tissue sampled was inadequate for a histological characterization; of these, 55 (83.3%) were taken using 3F forceps and 11 (16.7%) using BIGopsy forceps. No inadequate specimen arose using the 2.2F Nitinol Basket. Among 28 patients who underwent distal ureterectomy or RNU, the tumor was upgraded to high grade in 9 (32%), while in 19 (68%) the grading was confirmed.

Conclusion

In comparison to 3F forceps, the BIGopsy forceps showed to be more accurate in obtaining sufficient specimen for pathologic examination. In papillary lesions, the 2.2F Nitinol basket achieves a final histology characterization in 100% of the cases. For tumor < 2 cm, there is a high concordance between URS biopsy grade and final pathology (distal ureterectomy or RNU).
Literatur
1.
Zurück zum Zitat Rouprêt M et al (2018) European Association of Urology guidelines on upper urinary tract urothelial carcinoma: 2017 update. Eur Urol 73(1):111–122CrossRefPubMed Rouprêt M et al (2018) European Association of Urology guidelines on upper urinary tract urothelial carcinoma: 2017 update. Eur Urol 73(1):111–122CrossRefPubMed
2.
Zurück zum Zitat Babjuk M et al (2017) EAU guidelines on non–muscle-invasive urothelial carcinoma of the bladder: update 2016. Eur Urol 71(3):447–461CrossRefPubMed Babjuk M et al (2017) EAU guidelines on non–muscle-invasive urothelial carcinoma of the bladder: update 2016. Eur Urol 71(3):447–461CrossRefPubMed
3.
Zurück zum Zitat Margulis V et al (2009) Outcomes of radical nephroureterectomy: a series from the upper tract urothelial carcinoma collaboration. Cancer 115(6):1224–1233CrossRefPubMed Margulis V et al (2009) Outcomes of radical nephroureterectomy: a series from the upper tract urothelial carcinoma collaboration. Cancer 115(6):1224–1233CrossRefPubMed
4.
Zurück zum Zitat Grasso M, Fishman AI, Cohen J, Alexander B (2012) Ureteroscopic and extirpative treatment of upper urinary tract urothelial carcinoma: a 15-year comprehensive review of 160 consecutive patients. BJU Int 110(11):1618–1626CrossRefPubMed Grasso M, Fishman AI, Cohen J, Alexander B (2012) Ureteroscopic and extirpative treatment of upper urinary tract urothelial carcinoma: a 15-year comprehensive review of 160 consecutive patients. BJU Int 110(11):1618–1626CrossRefPubMed
5.
Zurück zum Zitat Rouprêt M et al (2007) Oncologic control after open or laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma: a single center experience. Urology 69(4):656–661CrossRefPubMed Rouprêt M et al (2007) Oncologic control after open or laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma: a single center experience. Urology 69(4):656–661CrossRefPubMed
6.
Zurück zum Zitat Wang L-J et al (2010) Multidetector computerized tomography urography is more accurate than excretory urography for diagnosing transitional cell carcinoma of the upper urinary tract in adults with hematuria. J Urol 183(1):48–55CrossRefPubMed Wang L-J et al (2010) Multidetector computerized tomography urography is more accurate than excretory urography for diagnosing transitional cell carcinoma of the upper urinary tract in adults with hematuria. J Urol 183(1):48–55CrossRefPubMed
7.
Zurück zum Zitat Straub J et al (2013) Ureterorenoscopic biopsy and urinary cytology according to the 2004 WHO classification underestimate tumor grading in upper urinary tract urothelial carcinoma. Urol Oncol 31(7):1166–1170CrossRefPubMed Straub J et al (2013) Ureterorenoscopic biopsy and urinary cytology according to the 2004 WHO classification underestimate tumor grading in upper urinary tract urothelial carcinoma. Urol Oncol 31(7):1166–1170CrossRefPubMed
8.
Zurück zum Zitat Clements T et al (2012) High-grade ureteroscopic biopsy is associated with advanced pathology of upper-tract urothelial carcinoma tumors at definitive surgical resection. J Endourol 26(4):398–402CrossRefPubMed Clements T et al (2012) High-grade ureteroscopic biopsy is associated with advanced pathology of upper-tract urothelial carcinoma tumors at definitive surgical resection. J Endourol 26(4):398–402CrossRefPubMed
9.
Zurück zum Zitat Rojas CP et al (2013) Low biopsy volume in ureteroscopy does not affect tumor biopsy grading in upper tract urothelial carcinoma. Urol Oncol 31(8):1696–1700CrossRefPubMed Rojas CP et al (2013) Low biopsy volume in ureteroscopy does not affect tumor biopsy grading in upper tract urothelial carcinoma. Urol Oncol 31(8):1696–1700CrossRefPubMed
10.
Zurück zum Zitat Lucca I et al (2015) Kidney-sparing surgery for upper tract urothelial cancer. Curr Opin Urol 25(2):100–104CrossRefPubMed Lucca I et al (2015) Kidney-sparing surgery for upper tract urothelial cancer. Curr Opin Urol 25(2):100–104CrossRefPubMed
11.
Zurück zum Zitat Lucca I et al (2015) Diagnosis and management of upper tract urothelial carcinoma. Hematol Oncol Clin N Am 29(2):271–288CrossRef Lucca I et al (2015) Diagnosis and management of upper tract urothelial carcinoma. Hematol Oncol Clin N Am 29(2):271–288CrossRef
12.
Zurück zum Zitat Satava RM et al (2005) Identification and reduction of surgical error using simulation. Minim Invasive Ther Allied Technol 14(4):257–261CrossRefPubMed Satava RM et al (2005) Identification and reduction of surgical error using simulation. Minim Invasive Ther Allied Technol 14(4):257–261CrossRefPubMed
13.
Zurück zum Zitat Dindo D et al (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213CrossRefPubMedPubMedCentral Dindo D et al (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Yakoubi R et al (2014) Radical nephroureterectomy versus endoscopic procedures for the treatment of localised upper tract urothelial carcinoma: a meta-analysis and a systematic review of current evidence from comparative studies. Eur J Surg Oncol 40(12):1629–1634CrossRefPubMed Yakoubi R et al (2014) Radical nephroureterectomy versus endoscopic procedures for the treatment of localised upper tract urothelial carcinoma: a meta-analysis and a systematic review of current evidence from comparative studies. Eur J Surg Oncol 40(12):1629–1634CrossRefPubMed
15.
Zurück zum Zitat Colin P et al (2012) Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study. BJU Int 110(8):1134–1141CrossRefPubMed Colin P et al (2012) Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study. BJU Int 110(8):1134–1141CrossRefPubMed
16.
Zurück zum Zitat Caoili EM et al (2002) Urinary tract abnormalities: initial experience with multi-detector row CT urography. Radiology 222(2):353–360CrossRefPubMed Caoili EM et al (2002) Urinary tract abnormalities: initial experience with multi-detector row CT urography. Radiology 222(2):353–360CrossRefPubMed
17.
Zurück zum Zitat Scolieri MJ et al (2000) Limitations of computed tomography in the preoperative staging of upper tract urothelial carcinoma. Urology 56(6):930–934CrossRefPubMed Scolieri MJ et al (2000) Limitations of computed tomography in the preoperative staging of upper tract urothelial carcinoma. Urology 56(6):930–934CrossRefPubMed
18.
Zurück zum Zitat Kupershmidt M et al (2011) Evaluation of upper urinary tract tumors with portal venous phase MDCT: a case-control study. AJR Am J Roentgenol 197(2):424–428CrossRefPubMed Kupershmidt M et al (2011) Evaluation of upper urinary tract tumors with portal venous phase MDCT: a case-control study. AJR Am J Roentgenol 197(2):424–428CrossRefPubMed
19.
Zurück zum Zitat Shiraishi K et al (2003) Role of ureteroscopic biopsy in the management of upper urinary tract malignancy. Int J Urol 10(12):627–630CrossRefPubMed Shiraishi K et al (2003) Role of ureteroscopic biopsy in the management of upper urinary tract malignancy. Int J Urol 10(12):627–630CrossRefPubMed
20.
Zurück zum Zitat Kleinmann N et al (2013) Ureteroscopic biopsy of upper tract urothelial carcinoma: comparison of basket and forcepss. J Endourol 27(12):1450–1454CrossRefPubMed Kleinmann N et al (2013) Ureteroscopic biopsy of upper tract urothelial carcinoma: comparison of basket and forcepss. J Endourol 27(12):1450–1454CrossRefPubMed
21.
Zurück zum Zitat Williams SK et al (2008) Correlation of upper-tract cytology, retrograde pyelography, ureteroscopic appearance, and ureteroscopic biopsy with histologic examination of upper-tract transitional cell carcinoma. J Endourol 22(1):71–76CrossRefPubMed Williams SK et al (2008) Correlation of upper-tract cytology, retrograde pyelography, ureteroscopic appearance, and ureteroscopic biopsy with histologic examination of upper-tract transitional cell carcinoma. J Endourol 22(1):71–76CrossRefPubMed
Metadaten
Titel
Comparison of biopsy devices in upper tract urothelial carcinoma
verfasst von
Alberto Breda
Angelo Territo
Francesco Sanguedolce
Giuseppe Basile
Jose D. Subiela
Helena Vila Reyes
Olga Mayordomo Ferrer
Jose M. Gaya
Joan Palou
Publikationsdatum
17.12.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 9/2019
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-018-2586-y

Weitere Artikel der Ausgabe 9/2019

World Journal of Urology 9/2019 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

Stufenschema weist Prostatakarzinom zuverlässig nach

22.04.2024 Prostatakarzinom Nachrichten

Erst PSA-Test, dann Kallikrein-Score, schließlich MRT und Biopsie – ein vierstufiges Screening-Schema kann die Zahl der unnötigen Prostatabiopsien erheblich reduzieren: Die Hälfte der Männer, die in einer finnischen Studie eine Biopsie benötigten, hatte einen hochgradigen Tumor.

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

20.04.2024 EAU 2024 Kongressbericht

Beim chronischen Harnwegsinfekt bei Frauen wird bisher meist eine Antibiotikaprophylaxe eingesetzt. Angesichts der zunehmenden Antibiotikaresistenz erweist sich das Antiseptikum Methenamin-Hippurat als vielversprechende Alternative, so die Auswertung einer randomisierten kontrollierten Studie.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.